logo

Stephen Tyring, MD

Stephen Tyring, MD

Dermatology Webster, TX

Physician

Office Address

Office Map
  • 451 N Texas Ave
    Webster, TX 77598
    Phone: (281) 333-2288
    Fax: (281) 335-4605

Summary

  • Dr. Stephen Tyring, MD is a board certified dermatologist in Webster, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Christus St. John Hospital, Clear Lake Regional Medical Center, and CHI Health / Baylor St. Luke’s Medical Center.

Dr. Tyring's Clinical Specialties & Interests

  • Dermatology: General Dermatology

Dr. Tyring's Education & Medical Training

  • University of Alabama Medical CenterUniversity of Alabama Medical CenterResidency, Dermatology
  • University of Texas Medical Branch HospitalsUniversity of Texas Medical Branch HospitalsResidency, Internal Medicine

Dr. Tyring's Certifications & Licensure

  • TX State Medical LicenseTX State Medical License1983 - 2016
  • American Board of DermatologyAmerican Board of DermatologyDermatology

Dr. Tyring's Awards, Honors, & Recognition

  • SuperDoctors.comSuper DoctorSuperDoctors.com
  • American Academy of DermatologyFellow (FAAD)American Academy of Dermatology

Dr. Tyring's Clinical Trials

Dr. Tyring's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Genetic Resistance To Oncogenic Human Papillomaviruses
    Genetic Resistance To Oncogenic Human PapillomavirusesNational Cancer Institute
    2004 - 2004
  • Genetic Resistance To Oncogenic Human Papillomaviruses
    Genetic Resistance To Oncogenic Human PapillomavirusesNational Cancer Institute
    2003 - 2003
  • ABT 606 VS Acyclovir For Treatment Of Herpes Zoster
    ABT 606 VS Acyclovir For Treatment Of Herpes ZosterNational Center For Research Resources
    1999 - 2002
  • Study Of Oral Lobucavir In Patients With Recurrent Genital Herpes
    Study Of Oral Lobucavir In Patients With Recurrent Genital HerpesNational Center For Research Resources
    1998 - 2002
  • Valacyclovir Therapy Of Shingles In Immunocompetent Patients
    Valacyclovir Therapy Of Shingles In Immunocompetent PatientsNational Center For Research Resources
    1998 - 2002
  • Efficacy Of Herpes Simplex Vaccine--Gd2t With MPL To Prevent Genital Herpes
    Efficacy Of Herpes Simplex Vaccine--Gd2t With MPL To Prevent Genital HerpesNational Center For Research Resources
    1998 - 2002
  • Valacyclovir Therapy Of Shingles In Immunocompromised Patients
    Valacyclovir Therapy Of Shingles In Immunocompromised PatientsNational Center For Research Resources
    1998 - 2002
  • Study Of Oral Lobucavir In Patients With Recurrent Herpes Labialis
    Study Of Oral Lobucavir In Patients With Recurrent Herpes LabialisNational Center For Research Resources
    1998 - 2000
  • Percutaneous Penetration Of Imiquimod For Treatment Of Genital Warts
    Percutaneous Penetration Of Imiquimod For Treatment Of Genital WartsNational Center For Research Resources
    1998 - 2000
  • Skin Preparation Effects On Absorption And Effectiveness Of EMLA Cream
    Skin Preparation Effects On Absorption And Effectiveness Of EMLA CreamNational Center For Research Resources
    1998 - 1999
  • Efficacy Of Herpes Simplex Vaccine With MPL To Prevent Genital Herpes
    Efficacy Of Herpes Simplex Vaccine With MPL To Prevent Genital HerpesNational Center For Research Resources
    1997 - 2000
  • Treatment Of Shingles Comparing Valacyclovir To Famciclovir
    Treatment Of Shingles Comparing Valacyclovir To FamciclovirNational Center For Research Resources
    1997 - 1999
  • Lot To Lot Comparison Of Herpes Virus Vaccine
    Lot To Lot Comparison Of Herpes Virus VaccineNational Center For Research Resources
    1997 - 1997
  • Sorivudine Effect On Dihydropyrimidine Dehydrogenase In Blood Of Zoster Patients
    Sorivudine Effect On Dihydropyrimidine Dehydrogenase In Blood Of Zoster PatientsNational Center For Research Resources
    1997 - 1997
  • Oral Famciclovir In The Suppression Of Recurrent Genital Herpes
    Oral Famciclovir In The Suppression Of Recurrent Genital HerpesNational Center For Research Resources
    1996 - 1997
  • HSV Vaccine Study In HSV2 Seronegative Sex Partners Of Persons With HSV2
    HSV Vaccine Study In HSV2 Seronegative Sex Partners Of Persons With HSV2National Center For Research Resources
    1996 - 1999
  • HSV Study In HSV2 Seronegative Adults At High Risk For STDS
    HSV Study In HSV2 Seronegative Adults At High Risk For STDSNational Center For Research Resources
    1996 - 1997
  • Comparison Of Sorivudine Versus Acyclovir For Treatment Of Herpes Zoster
    Comparison Of Sorivudine Versus Acyclovir For Treatment Of Herpes ZosterNational Center For Research Resources
    1996 - 1997
  • Famciclovir Versus Placebo On Herpes Zoster Induced Pain
    Famciclovir Versus Placebo On Herpes Zoster Induced PainNational Center For Research Resources
    1996 - 1996
  • Penciclovir Cream VS Placebo In Patients With Recurrent Oral HSV Infection
    Penciclovir Cream VS Placebo In Patients With Recurrent Oral HSV InfectionNational Center For Research Resources
    1994 - 1994
  • Dose Response Trial Of 882c87 VS Acyclovir For Treatment Of Zoster Patients
    Dose Response Trial Of 882c87 VS Acyclovir For Treatment Of Zoster PatientsNational Center For Research Resources
    1994 - 1994
  • Valacyclovir (256U87) VS Acyclovir In First Episode Genital HSV
    Valacyclovir (256U87) VS Acyclovir In First Episode Genital HSVNational Center For Research Resources
    1994 - 1994
  • Valacyclovir In Immunocompetent Patients With Recurrent Genital HSV
    Valacyclovir In Immunocompetent Patients With Recurrent Genital HSVNational Center For Research Resources
    1994 - 1994
  • Collaborative Study Of Localized Cutaneous Zoster In The Normal Host
    Collaborative Study Of Localized Cutaneous Zoster In The Normal HostNational Center For Research Resources
    1994 - 1994
  • Oral 882c87 VS Oral Acyclovir Therapy For Herpes Zoster Immunocompromised PTS
    Oral 882c87 VS Oral Acyclovir Therapy For Herpes Zoster Immunocompromised PTSNational Center For Research Resources
    1994 - 1994
  • Famciclovir VS Acyclovir For Treatment Of Uncomplicated Herpes Zoster
    Famciclovir VS Acyclovir For Treatment Of Uncomplicated Herpes ZosterNational Center For Research Resources
    1994 - 1994
  • Oral Famciclovir In The Suppression Of Recurrent Genital Herpes Infection
    Oral Famciclovir In The Suppression Of Recurrent Genital Herpes InfectionNational Center For Research Resources
    1993 - 1994
  • Oral Acyclovir VS Oral 256u87 In Immunocompetent Zoster Patients Over 50 Years
    Oral Acyclovir VS Oral 256u87 In Immunocompetent Zoster Patients Over 50 YearsNational Center For Research Resources
    1993 - 1993
  • Oral 256u87 VS Acyclovir For Recurrent Ano-Genital Herpes In HIV Infection
    Oral 256u87 VS Acyclovir For Recurrent Ano-Genital Herpes In HIV InfectionNational Center For Research Resources
    1993 - 1994
  • Famciclovir (Oral BRL 42810) In Treatment Of Uncomplicated Herpes Zoster
    Famciclovir (Oral BRL 42810) In Treatment Of Uncomplicated Herpes ZosterNational Center For Research Resources
    1993 - 1994
  • Oral 256u87 For Herpes Zoster In Immunocompetent Patients LESS THAN 50 Years
    Oral 256u87 For Herpes Zoster In Immunocompetent Patients LESS THAN 50 YearsNational Center For Research Resources
    1993 - 1994
  • Compare 256u87 To Acyclovir In Ano-Genital Herpes In Hiv-Infected Patients
    Compare 256u87 To Acyclovir In Ano-Genital Herpes In Hiv-Infected PatientsNational Center For Research Resources
    1993 - 1994
  • Dose Response Trial Of 882c87 VS Acyclovir In Zoster In Healthy Patients Over 50
    Dose Response Trial Of 882c87 VS Acyclovir In Zoster In Healthy Patients Over 50National Center For Research Resources
    1993 - 1993
  • Intralesional Interferon Alpha Treatment Of Recurrent Genital Herpes
    Intralesional Interferon Alpha Treatment Of Recurrent Genital HerpesNational Center For Research Resources
    1993 - 1993
  • Famciclovir (Oral 42810) In Treatment Of Uncomplicated Herpes Zoster
    Famciclovir (Oral 42810) In Treatment Of Uncomplicated Herpes ZosterNational Center For Research Resources
    1992 - 1992
  • Oral 256u87 For Recurrent Genital Herpes In Immunocompetent Patients
    Oral 256u87 For Recurrent Genital Herpes In Immunocompetent PatientsNational Center For Research Resources
    1992 - 1993
  • Oral Acyclovir VS Placebo And Adjunctive Therapy In Herpes Zoster
    Oral Acyclovir VS Placebo And Adjunctive Therapy In Herpes ZosterNational Center For Research Resources
    1992 - 1993
  • Intralesional Interferon Alpha Treatment Or Recurrent Genital Herpes
    Intralesional Interferon Alpha Treatment Or Recurrent Genital HerpesNational Center For Research Resources
    1992 - 1992
  • Oral 256u87 VS Acyclovir For Recurrent Ano-Genital Herpes In HIV Infected PTS
    Oral 256u87 VS Acyclovir For Recurrent Ano-Genital Herpes In HIV Infected PTSNational Center For Research Resources
    1992 - 1992
  • Mechanisms Of Interferon Action Against Human Papillomaviruses
    Mechanisms Of Interferon Action Against Human PapillomavirusesNational Center For Research Resources
    1990 - 1994
  • Oral Acyclovir In Immunocompromised Patients With Herpes Zoster
    Oral Acyclovir In Immunocompromised Patients With Herpes ZosterNational Center For Research Resources
    1990 - 1994
  • Mechanisms Of Interferon Action Against Papillomaviruses
    Mechanisms Of Interferon Action Against PapillomavirusesNational Institute Of Allergy And Infectious Diseases
    1989 - 1989

Dr. Tyring's Professional Memberships

  • FellowAmerican Academy of Dermatology - AADFellow

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS Texas BlueChoice
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Alternate Names

  • Dr. Stephen Tyring, Dr. Stephen Tyring, MD, Dr. S Tyring, Dr. Stephen Keith Tyring

32 Colleague Invites!
Is this you? If so, register to see 32 messages.

Physicians, view Dr. Tyring's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV